bevacizumab,panitumumab
amgen,roche,takeda
['bevacizumab', 'paradigm', 'beva']
#paradigm trial first-line panitumab is superior to bevacizumab in the left-sided ras wild metastatic colon cancer #asco22 
Medical oncologist